Response Genetics, Inc. (RGDX) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RGDX Hot Sheet
Join SI Premium – FREE
Response Genetics, Inc. (NASDAQ: RGDX) reported Q2 loss of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $5.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Acuity Brands (AYI) Tops Q4 EPS by 11c
- Cal-Maine Foods (CALM) Misses Q1 EPS by 79c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
